Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

What's In Store For Scotts Miracle-Gro (SMG) In Q2 Earnings?

Published 04/28/2019, 11:00 PM
Updated 07/09/2023, 06:31 AM

The Scotts Miracle-Gro Company (NYSE:SMG) is set to release second-quarter fiscal 2019 results on May 1, before the opening bell.

The stock has rallied 35.6% year to date, outperforming the industry’s 6.3% rise.



Few of the Factors at Play

Scotts Miracle-Gro is witnessing its U.S. retailers getting engaged for the lawn and garden season. During first-quarter fiscal 2019 earnings call, the company stated that it expects to see positive top-line growth in the fiscal second quarter, provided run rate exiting January 2019 sustains.

The company expects the trends in the Hawthorne segment to be positive on a year-over-year basis. Scotts Miracle-Gro is also expected to benefit from the synergies of the Sunlight Supply acquisition in the to-be-reported quarter.

What do the Estimates Say?

The Zacks Consensus Estimate for fiscal second-quarter revenues is currently pegged at $1,161 million, suggesting an increase of 14.6% year over year.

The Zacks Consensus Estimate for fiscal second-quarter sales in the Hawthorne segment is currently pegged at $112 million, calling for an increase of 167.9% from the year-ago quarter's figure.

Zacks Model

Our proven model does not show that Scotts Miracle-Gro is likely to beat in the estimates to-be-reported quarter. That is because a stock needs to have a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here, as you will see below:

Earnings ESP: Earnings ESP for Scotts Miracle-Gro is 0.00%. The Most Accurate Estimate and the Zacks Consensus Estimate are both currently pegged at $3.42. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Zacks Rank: Scotts Miracle-Gro currently carries a Zacks Rank #2, which when combined with a 0.00% ESP makes surprise prediction difficult. You can see the complete list of today’s Zacks #1 Rank stocks here.

Note that we caution against stocks with a Zacks Rank #4 (Sell) or #5 (Strong Sell) going into the earnings announcement, especially when the company is seeing negative estimate revisions.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Stocks Poised to Beat Estimates

Here are some companies in the same space you may want to consider as our model shows that they have the right combination of elements to beat estimates.

Intrepid Potash, Inc (NYSE:IPI) has an Earnings ESP of +25.00% and carries a Zacks Rank #2.

Ingevity Corporation (NYSE:NGVT) has an Earnings ESP of +6.77% and carries a Zacks Rank #3.

Ternium S.A. (NYSE:TX) has an Earnings ESP of +6.21% and carries a Zacks Rank #3.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>



Ingevity Corporation (NGVT): Free Stock Analysis Report

Intrepid Potash, Inc (IPI): Free Stock Analysis Report

The Scotts Miracle-Gro Company (SMG): Free Stock Analysis Report

Ternium S.A. (TX): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.